An integrated multi-omics analysis of sleep-disordered breathing traits implicates P2XR4 purinergic signaling

Commun Biol. 2023 Jan 31;6(1):125. doi: 10.1038/s42003-023-04520-y.


Sleep Disordered Breathing (SDB) is a common disease associated with increased risk for cardiometabolic, cardiovascular, and cognitive diseases. How SDB affects the molecular environment is still poorly understood. We study the association of three SDB measures with gene expression measured using RNA-seq in multiple blood tissues from the Multi-Ethnic Study of Atherosclerosis. We develop genetic instrumental variables for the associated transcripts as polygenic risk scores (tPRS), then generalize and validate the tPRS in the Women's Health Initiative. We measure the associations of the validated tPRS with SDB and serum metabolites in Hispanic Community Health Study/Study of Latinos. Here we find differential gene expression by blood cell type in relation to SDB traits and link P2XR4 expression to average oxyhemoglobin saturation during sleep and butyrylcarnitine (C4) levels. These findings can be used to develop interventions to alleviate the effect of SDB on the human molecular environment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hispanic or Latino
  • Humans
  • Multifactorial Inheritance
  • Multiomics*
  • Oxyhemoglobins
  • Receptors, Purinergic P2X7
  • Sleep
  • Sleep Apnea Syndromes* / genetics


  • P2RX7 protein, human
  • Oxyhemoglobins
  • Receptors, Purinergic P2X7
  • butyrylcarnitine